🔎 Trials Near Me

Gara Jalqabaatti › Kansaar Onnee Triple-Negative › New Jersey › Edison

Qorannoo klinikaalii Kansaar Onnee Triple-Negative Edison, NJ keessatti

Qorannoo 11 Kansaar Onnee Triple-Negative f Edison fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • START New Jersey, East Brunswick · Miili 6 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06270706

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

Namoota walitti qabaa jira
  • Cooper Hospital Univ Med Ctr, MD Anderson at Cooper Voorhees, Voorhees Township · Miili 5 fagaatti
Umuriin 30 fi ol · Dubartoota · Haaromfame 25-Ful-2026 · NCT02945579

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Namoota walitti qabaa jiraSadarkaa 3
  • Rutgers Cancer Institute of New Jersey ( Site 0076), New Brunswick · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06966700

A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities), Basking Ridge · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06246968

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT05570253

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Namoota walitti qabaa jiraSadarkaa 3
  • Rutgers Health, New Brunswick · Miili 3 fagaatti
  • Regional Cancer Care Associates LLC, East Brunswick · Miili 6 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT05633654

A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · Miili 15 fagaatti
Umuriin 70 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT07768436

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT01042379

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Gur-2026 · NCT03808337

A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · Miili 15 fagaatti
Umuriin 18 fi ol · Dubartoota · Haaromfame 17-Gur-2026 · NCT04683679

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Wax-2025 · NCT06568692

Qorannoo Kansaar Onnee Triple-Negative magaalota biroo keessatti

Qorannoo biroo Edison keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.